Asbestos testing by polarized light microscopy added to laboratory testing scope at Portland, Maine laboratory (PRWeb April 06, 2015) Read the full story at http://www.prweb.com/releases/2015/04/prweb12628884.htm
Study Finds Surgery May Decrease Lung Function in Mesothelioma Patients with Few Symptoms, According to Surviving …
New research out of the University of Chicago may give some mesothelioma patients reason to rethink surgery.
Roswell Park Cancer Institute’s 15th and first female president, Dr.
April 12th Launch Party Entertains Los Angeles’ Elite and Celebrates West Coast Presence (PRWeb April 02, 2015) Read the full story at http://www.prweb.com/releases/2015/04/prweb12627221.htm
New Research Finds Immunotherapy Drug May Fight Mesothelioma Better at Higher Doses, According to Surviving Mesothelioma
Scientists say an intensified dosing schedule of a monoclonal antibody called tremelimumab may be the key to fighting advanced mesothelioma when chemotherapy fails. (PRWeb April 01, 2015) Read the full story at http://www.prweb.com/releases/2015/04/prweb12622367.htm
New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma
Researchers in Italy say they have come up with a way to make cancer-fighting curcumin more accessible to mesothelioma cells.
Mesothelioma lawyers of The Law Office of Melinda J. Helbock A.P.C. provide commentary on a possible breakthrough in treating mesothelioma with drugs currently used to treat Hodgkin’s disease and large-cell lymphoma.
New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma
New genome sequencing work by scientists in Canada and the U.S. is paving the way for a more personalized approach to mesothelioma therapy.
Study Finds Closed HIPEC Technique May Be Better for Frail Mesothelioma Patients, According to Surviving Mesothelioma
A new study suggests that certain peritoneal mesothelioma patients who undergo heated intraperitoneal chemotherapy (HIPEC) after surgery may have better outcomes with a closed abdomen technique than an open one. (PRWeb March 25, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12601942.htm
Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019; Biosimilars Proving to be a Major Driving Factor
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. (PRWeb March 24, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12592291.htm